Industry for Stem Cell Therapy will generate massive revenue by 2027
According to a new market research study of ‘Stem Cell therapy Market to 2027 – Global Analysis and Forecasts by Type, Treatment, Application, and End User.’ The global stem cell therapy market is expected to reach US$ 5,129.66 Mn in 2027 from US$ 1,534.55 Mn in 2019. The market is estimated to grow with a CAGR of 16.7% from 2020-2027. The report provides trends prevailing in the global stem cell therapy market and the factors driving market along with those that act as hindrances.
Get Sample Copy@ https://www.theinsightpartners.com/sample/TIPHE100000991/
Stem cells are preliminary body
cells from which all other cells with specialized functions are generated.
Under controlled environment in the body or a clinical laboratory, these cells
divide to form more cells called daughter cells. Due to the advent of modern
health science, these cells play a major role in understanding the occurrence
of diseases, generation of advanced regenerative medicines, and drug discovery.
Growing healthcare industry and
increasing awareness about benefits offered by stem cell therapies in
developing countries of Asia Pacific creates better opportunities for market
players to expand their business. The huge patient population in emerging
countries is generating demand for advanced therapeutic solutions to deal with
exponentially accelerating chronic conditions. Additionally, favourable
regulatory policies and financial aids to bolster stem cell therapies are
likely to drive the adoption of these advanced therapies during the forecast
period. For instance, in 2012, China’s
State Food and Drug Administration (SFDA) approved the direct commercial sale
of the Bio Archive System (Bio Archive), which is developed by ThermoGenesis
Corp. in China. Bio Archive System is an automated processing and storage
solution that is utilized in the management of stem cells.
The global stem cell therapy
market, based on applications, is segmented into musculoskeletal, dermatology,
cardiology, drug discovery and development, and other applications. In 2019,
the musculoskeletal segment accounted for the largest market share in the
global stem cell therapy market. Additionally, this segment is expected to grow
at faster pace in the forecasted period as well. The growth of the segment is
attributed to increasing prevalence of musculoskeletal conditions and growing
geriatric population. For instance, according to the Global Burden of Disease
(GBD) 2017, musculoskeletal conditions were the highest contributor to global
disability. Furthermore, superior treatment outcomes offered by stem cell
therapies are projected to indicate positive impact on acceptance of stem cell
therapies in years to come.
Contact Us:
Contact Person: Sameer Joshi
E-mail: sales@theinsightpartners.com
Phone: +1-646-491-9876
Comments
Post a Comment